335 related articles for article (PubMed ID: 25688454)
1. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
[TBL] [Abstract][Full Text] [Related]
2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
3. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
[TBL] [Abstract][Full Text] [Related]
5. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
7. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
[TBL] [Abstract][Full Text] [Related]
8. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
Perrone J; DeRoos FJ; Nelson LS
J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
[TBL] [Abstract][Full Text] [Related]
9. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
10. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
11. Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study.
Poon SJ; Greenwood-Ericksen MB; Gish RE; Neri PM; Takhar SS; Weiner SG; Schuur JD; Landman AB
Acad Emerg Med; 2016 Apr; 23(4):406-14. PubMed ID: 26806310
[TBL] [Abstract][Full Text] [Related]
12. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
13. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
[TBL] [Abstract][Full Text] [Related]
14. Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.
Freeman PR; Curran GM; Drummond KL; Martin BC; Teeter BS; Bradley K; Schoenberg N; Edlund MJ
Res Social Adm Pharm; 2019 Jun; 15(6):754-760. PubMed ID: 30243575
[TBL] [Abstract][Full Text] [Related]
15. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool.
Gershman JA; Gershman JA; Fass AD; Popovici I
Pain Med; 2014 Dec; 15(12):2013-9. PubMed ID: 24931295
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
18. Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program Data.
Hildebran C; Leichtling G; Irvine JM; Cohen DJ; Hallvik SE; Deyo RA
Pain Med; 2016 Nov; 17(11):2061-2066. PubMed ID: 27009292
[TBL] [Abstract][Full Text] [Related]
19. Optimal Implementation of Prescription Drug Monitoring Programs in the Emergency Department.
Elder JW; DePalma G; Pines JM
West J Emerg Med; 2018 Mar; 19(2):387-391. PubMed ID: 29560070
[TBL] [Abstract][Full Text] [Related]
20. Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.
Leichtling GJ; Irvine JM; Hildebran C; Cohen DJ; Hallvik SE; Deyo RA
Pain Med; 2017 Jun; 18(6):1063-1069. PubMed ID: 27794549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
